Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

And Amp, can you imagine the number of people who wanted to be with their love ones a little longer or perhaps for a number of years only to be stopped by pure greed.

I presume this statement is aimed at AF or Favus or the FDA. And Favus and Cramer might be dirtbags, (I don't like them as my posts indicated for years) and have been flipping coins on this stock; it turns out they were 100% correct on 45mg AEs and pps.

Favus said lots of AEs, no first line, and Cramer said he'd only buy us at $7 when we were at $15 or so. He was always saying to buy at 30% of the price at the time (Above $8). We went to $2.15. These are documented facts, and all the arm waving, fist pounding, complaining anyone can muster won't change them. There is a reason there is no suit against AF for Ariad.

No investor, including the parade of institutions, or good friends from this board that left the stock in Oct., could have any bearing on any patient. Not even the shorts or the mob that took the stock down.

In the end, it wasn't even the FDA. As I wrote to ARIAD BoD and management:

...Worst of all, the travails the legacy board have brought down on Ariad with their poor decisions on its primary valuation asset, Ponatinib, have been extraordinarily wasteful to every stakeholder, be it the patients who have elected or been forced to leave trials, associated physicians, Ariad line employees, investors and stockholders, and others. Many patients will not benefit from extended use of the drug due to label restrictions resulting from Ariad’s maladministration of the Ponatinib program...

It's that simple. So who are to blame? Ariad themselves.